ARKEMA (AKE.PA) Fundamental Analysis & Valuation

EPA:AKE • FR0010313833

Current stock price

61.6 EUR
+0.75 (+1.23%)
Last:

This AKE.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. AKE.PA Profitability Analysis

1.1 Basic Checks

  • AKE had positive earnings in the past year.
  • In the past year AKE had a positive cash flow from operations.
  • AKE had positive earnings in each of the past 5 years.
  • AKE had a positive operating cash flow in each of the past 5 years.
AKE.PA Yearly Net Income VS EBIT VS OCF VS FCFAKE.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B

1.2 Ratios

  • The Return On Assets of AKE (0.27%) is comparable to the rest of the industry.
  • The Return On Equity of AKE (0.57%) is comparable to the rest of the industry.
  • Looking at the Return On Invested Capital, with a value of 1.90%, AKE is in line with its industry, outperforming 42.03% of the companies in the same industry.
  • AKE had an Average Return On Invested Capital over the past 3 years of 2.66%. This is below the industry average of 7.13%.
Industry RankSector Rank
ROA 0.27%
ROE 0.57%
ROIC 1.9%
ROA(3y)1.76%
ROA(5y)4.56%
ROE(3y)3.55%
ROE(5y)8.83%
ROIC(3y)2.66%
ROIC(5y)4.13%
AKE.PA Yearly ROA, ROE, ROICAKE.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1.3 Margins

  • The Profit Margin of AKE (0.43%) is comparable to the rest of the industry.
  • In the last couple of years the Profit Margin of AKE has declined.
  • AKE has a Operating Margin (4.63%) which is in line with its industry peers.
  • AKE's Operating Margin has declined in the last couple of years.
  • AKE has a Gross Margin of 17.80%. This is in the lower half of the industry: AKE underperforms 75.36% of its industry peers.
  • AKE's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 4.63%
PM (TTM) 0.43%
GM 17.8%
OM growth 3Y-28.32%
OM growth 5Y-8.39%
PM growth 3Y-62.59%
PM growth 5Y-35.51%
GM growth 3Y-7.29%
GM growth 5Y-1.94%
AKE.PA Yearly Profit, Operating, Gross MarginsAKE.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

4

2. AKE.PA Health Analysis

2.1 Basic Checks

  • AKE has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • AKE has less shares outstanding than it did 1 year ago.
  • AKE has less shares outstanding than it did 5 years ago.
  • AKE has a worse debt/assets ratio than last year.
AKE.PA Yearly Shares OutstandingAKE.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
AKE.PA Yearly Total Debt VS Total AssetsAKE.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.2 Solvency

  • AKE has an Altman-Z score of 1.76. This is a bad value and indicates that AKE is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of AKE (1.76) is worse than 71.01% of its industry peers.
  • AKE has a debt to FCF ratio of 13.85. This is a negative value and a sign of low solvency as AKE would need 13.85 years to pay back of all of its debts.
  • AKE has a Debt to FCF ratio (13.85) which is in line with its industry peers.
  • A Debt/Equity ratio of 0.56 indicates that AKE is somewhat dependend on debt financing.
  • AKE has a Debt to Equity ratio (0.56) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.56
Debt/FCF 13.85
Altman-Z 1.76
ROIC/WACC0.41
WACC4.7%
AKE.PA Yearly LT Debt VS Equity VS FCFAKE.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.3 Liquidity

  • AKE has a Current Ratio of 2.13. This indicates that AKE is financially healthy and has no problem in meeting its short term obligations.
  • AKE's Current ratio of 2.13 is fine compared to the rest of the industry. AKE outperforms 66.67% of its industry peers.
  • AKE has a Quick Ratio of 1.63. This is a normal value and indicates that AKE is financially healthy and should not expect problems in meeting its short term obligations.
  • AKE's Quick ratio of 1.63 is fine compared to the rest of the industry. AKE outperforms 73.91% of its industry peers.
Industry RankSector Rank
Current Ratio 2.13
Quick Ratio 1.63
AKE.PA Yearly Current Assets VS Current LiabilitesAKE.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

3

3. AKE.PA Growth Analysis

3.1 Past

  • The earnings per share for AKE have decreased strongly by -47.50% in the last year.
  • The Earnings Per Share has been decreasing by -3.31% on average over the past years.
  • Looking at the last year, AKE shows a decrease in Revenue. The Revenue has decreased by -4.99% in the last year.
  • AKE shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.84% yearly.
EPS 1Y (TTM)-47.5%
EPS 3Y-34.91%
EPS 5Y-3.31%
EPS Q2Q%-66.14%
Revenue 1Y (TTM)-4.99%
Revenue growth 3Y-7.75%
Revenue growth 5Y2.84%
Sales Q2Q%-7.39%

3.2 Future

  • Based on estimates for the next years, AKE will show a quite strong growth in Earnings Per Share. The EPS will grow by 11.99% on average per year.
  • The Revenue is expected to grow by 2.68% on average over the next years.
EPS Next Y10.82%
EPS Next 2Y15.19%
EPS Next 3Y15.67%
EPS Next 5Y11.99%
Revenue Next Year0.21%
Revenue Next 2Y1.55%
Revenue Next 3Y1.99%
Revenue Next 5Y2.68%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
AKE.PA Yearly Revenue VS EstimatesAKE.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2B 4B 6B 8B 10B
AKE.PA Yearly EPS VS EstimatesAKE.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5 10 15

7

4. AKE.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 14.29, AKE is valued correctly.
  • Compared to the rest of the industry, the Price/Earnings ratio of AKE indicates a rather cheap valuation: AKE is cheaper than 81.16% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 26.86, AKE is valued a bit cheaper.
  • The Price/Forward Earnings ratio is 12.90, which indicates a correct valuation of AKE.
  • Based on the Price/Forward Earnings ratio, AKE is valued cheaply inside the industry as 82.61% of the companies are valued more expensively.
  • AKE is valuated cheaply when we compare the Price/Forward Earnings ratio to 37.39, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 14.29
Fwd PE 12.9
AKE.PA Price Earnings VS Forward Price EarningsAKE.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AKE indicates a rather cheap valuation: AKE is cheaper than 86.96% of the companies listed in the same industry.
  • 82.61% of the companies in the same industry are more expensive than AKE, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 14.24
EV/EBITDA 5.6
AKE.PA Per share dataAKE.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

  • AKE's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • AKE's earnings are expected to grow with 15.67% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.32
PEG (5Y)N/A
EPS Next 2Y15.19%
EPS Next 3Y15.67%

7

5. AKE.PA Dividend Analysis

5.1 Amount

  • AKE has a Yearly Dividend Yield of 5.92%, which is a nice return.
  • AKE's Dividend Yield is rather good when compared to the industry average which is at 2.31. AKE pays more dividend than 95.65% of the companies in the same industry.
  • AKE's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 5.92%

5.2 History

  • The dividend of AKE is nicely growing with an annual growth rate of 10.37%!
Dividend Growth(5Y)10.37%
Div Incr Years4
Div Non Decr Years5
AKE.PA Yearly Dividends per shareAKE.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3

5.3 Sustainability

  • 697.44% of the earnings are spent on dividend by AKE. This is not a sustainable payout ratio.
  • AKE's earnings are growing around the same pace than its dividend. As long as the earnings growth is kept the dividend growth is sustainable.
DP697.44%
EPS Next 2Y15.19%
EPS Next 3Y15.67%
AKE.PA Yearly Income VS Free CF VS DividendAKE.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
AKE.PA Dividend Payout.AKE.PA Dividend Payout, showing the Payout Ratio.AKE.PA Dividend Payout.PayoutRetained Earnings

AKE.PA Fundamentals: All Metrics, Ratios and Statistics

ARKEMA

EPA:AKE (4/10/2026, 7:00:00 PM)

61.6

+0.75 (+1.23%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)02-26
Earnings (Next)05-06
Inst Owners58.04%
Inst Owner ChangeN/A
Ins Owners0.61%
Ins Owner ChangeN/A
Market Cap4.69B
Revenue(TTM)9.07B
Net Income(TTM)39.00M
Analysts72.73
Price Target63.99 (3.88%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.92%
Yearly Dividend3.59
Dividend Growth(5Y)10.37%
DP697.44%
Div Incr Years4
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-24.85%
Min EPS beat(2)-39.37%
Max EPS beat(2)-10.34%
EPS beat(4)0
Avg EPS beat(4)-16.25%
Min EPS beat(4)-39.37%
Max EPS beat(4)-6.61%
EPS beat(8)2
Avg EPS beat(8)-8.47%
EPS beat(12)5
Avg EPS beat(12)-4.27%
EPS beat(16)9
Avg EPS beat(16)3.1%
Revenue beat(2)1
Avg Revenue beat(2)0.01%
Min Revenue beat(2)-1.17%
Max Revenue beat(2)1.2%
Revenue beat(4)1
Avg Revenue beat(4)-0.34%
Min Revenue beat(4)-1.17%
Max Revenue beat(4)1.2%
Revenue beat(8)2
Avg Revenue beat(8)-0.43%
Revenue beat(12)3
Avg Revenue beat(12)-1.01%
Revenue beat(16)7
Avg Revenue beat(16)-0.03%
PT rev (1m)0.97%
PT rev (3m)0.07%
EPS NQ rev (1m)1.53%
EPS NQ rev (3m)-32.95%
EPS NY rev (1m)-2.95%
EPS NY rev (3m)-10.95%
Revenue NQ rev (1m)-0.64%
Revenue NQ rev (3m)1.16%
Revenue NY rev (1m)-0.04%
Revenue NY rev (3m)-1.21%
Valuation
Industry RankSector Rank
PE 14.29
Fwd PE 12.9
P/S 0.52
P/FCF 14.24
P/OCF 4.7
P/B 0.68
P/tB 2.55
EV/EBITDA 5.6
EPS(TTM)4.31
EY7%
EPS(NY)4.78
Fwd EY7.75%
FCF(TTM)4.33
FCFY7.02%
OCF(TTM)13.11
OCFY21.28%
SpS119.22
BVpS89.97
TBVpS24.14
PEG (NY)1.32
PEG (5Y)N/A
Graham Number93.41
Profitability
Industry RankSector Rank
ROA 0.27%
ROE 0.57%
ROCE 3.5%
ROIC 1.9%
ROICexc 2.33%
ROICexgc 4.77%
OM 4.63%
PM (TTM) 0.43%
GM 17.8%
FCFM 3.63%
ROA(3y)1.76%
ROA(5y)4.56%
ROE(3y)3.55%
ROE(5y)8.83%
ROIC(3y)2.66%
ROIC(5y)4.13%
ROICexc(3y)3.19%
ROICexc(5y)5.03%
ROICexgc(3y)6.48%
ROICexgc(5y)9.7%
ROCE(3y)4.96%
ROCE(5y)7.74%
ROICexgc growth 3Y-32.65%
ROICexgc growth 5Y-8.51%
ROICexc growth 3Y-33.65%
ROICexc growth 5Y-10.69%
OM growth 3Y-28.32%
OM growth 5Y-8.39%
PM growth 3Y-62.59%
PM growth 5Y-35.51%
GM growth 3Y-7.29%
GM growth 5Y-1.94%
F-Score6
Asset Turnover0.64
Health
Industry RankSector Rank
Debt/Equity 0.56
Debt/FCF 13.85
Debt/EBITDA 3.02
Cap/Depr 79.71%
Cap/Sales 7.37%
Interest Coverage 17.5
Cash Conversion 79.25%
Profit Quality 843.59%
Current Ratio 2.13
Quick Ratio 1.63
Altman-Z 1.76
F-Score6
WACC4.7%
ROIC/WACC0.41
Cap/Depr(3y)89.68%
Cap/Depr(5y)93.13%
Cap/Sales(3y)7.49%
Cap/Sales(5y)7.36%
Profit Quality(3y)365.95%
Profit Quality(5y)238.07%
High Growth Momentum
Growth
EPS 1Y (TTM)-47.5%
EPS 3Y-34.91%
EPS 5Y-3.31%
EPS Q2Q%-66.14%
EPS Next Y10.82%
EPS Next 2Y15.19%
EPS Next 3Y15.67%
EPS Next 5Y11.99%
Revenue 1Y (TTM)-4.99%
Revenue growth 3Y-7.75%
Revenue growth 5Y2.84%
Sales Q2Q%-7.39%
Revenue Next Year0.21%
Revenue Next 2Y1.55%
Revenue Next 3Y1.99%
Revenue Next 5Y2.68%
EBIT growth 1Y-41.5%
EBIT growth 3Y-33.87%
EBIT growth 5Y-5.79%
EBIT Next Year129.39%
EBIT Next 3Y38.89%
EBIT Next 5Y24.49%
FCF growth 1Y-8.61%
FCF growth 3Y-24.55%
FCF growth 5Y-8.39%
OCF growth 1Y-11.06%
OCF growth 3Y-12.65%
OCF growth 5Y-2.21%

ARKEMA / AKE.PA Fundamental Analysis FAQ

What is the fundamental rating for AKE stock?

ChartMill assigns a fundamental rating of 4 / 10 to AKE.PA.


Can you provide the valuation status for ARKEMA?

ChartMill assigns a valuation rating of 7 / 10 to ARKEMA (AKE.PA). This can be considered as Undervalued.


Can you provide the profitability details for ARKEMA?

ARKEMA (AKE.PA) has a profitability rating of 3 / 10.


What are the PE and PB ratios of ARKEMA (AKE.PA) stock?

The Price/Earnings (PE) ratio for ARKEMA (AKE.PA) is 14.29 and the Price/Book (PB) ratio is 0.68.


Can you provide the financial health for AKE stock?

The financial health rating of ARKEMA (AKE.PA) is 4 / 10.